Arch Biopartners Inc V.ARCH

Buzz on the Bullboards: Bombardier, world woes, a smart fridge, and top shelf weed

[Viking2233]

    But so does the nefarious shorting algorithms!    In my humble opinion the lack of communication and updates, just plays into the hands of those shorting.   I

[Jonathon Brown]

A highlight of the week was Bombardier (TSX:BBD), which reported impressive growth in its Q3 2024 results. read article.

[Viking2233]

Arch update   Well I wish I had something positive to report. I only have my observations and opinions.   We are 9 months into dosing in Turkey at 5 sites. Arch management reluctant

[PressRelease]

TORONTO, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that patient recruitment and dosing have begun in Canada for the Phase II trial for LSALT peptide targeting the prevention and treatment of cardiac...read article.

[Viking2233]

Thanks for this River, I have been saying this for months. We are ready to launch, glad I am not yhe only one who can see this!

[Riverfolk]

Globe and Mail Article

[Viking2233]

1. Been dosing at 5 Turkish sites for 9 months now. Silence from management but no news in this case could be great news as no adverse reactions reported.   2. How many patients dosed? Nobody

[Viking2233]

Some interesting facts for consideration. The Stockholm conference runs from November 4 to 13. This is a 9 day conference that we are presenting at. I wonder who we are sending and how many days will

[Viking2233]

Well today marks conference number 1 that Arch is attending. I errored in my previous post stating they were presenting, in fact they are simply attending but hopefully networking aggressively. That

[Viking2233]

Arch manangement announced on X yesterday that it will be presenting at 2 conferences starting Oct 23 in San Diego California and in November in Stockholm Sweden. Now one thing we know is Arch CEO is

[PressRelease]

TORONTO, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced it has arranged a non-brokered private placement offering of 290,323 common shares priced at $1.55 per common share (the “Common Shares”) for gross...read article.

[Viking2233]

At some point and time the markets will finally wake up and realize that Arch has been dosing at 5 sites for almost 8 months. We have no idea how many patients have been dosed but we know that there

[Viking2233]

How long does it take in Canada to get ethics approval and provincial approval for drug trial????? We have FDA and Health Canada approval plus we have been dosing in Turkey at 5 sites with no adverse

[PressRelease]

TORONTO, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today that the Company has closed a transaction that was previously announced on September 26, 2024 to settle an aggregate total of $2,600,000 of principal...read article.

[Viking2233]

Nice to see share price finally moving in the right direction. It's simply amazing how the share price reacts when the shorts take a pause. We are almost 8 months into dosing at 5 sites in Turkey

[PressRelease]

TORONTO, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today that the Company has arranged a transaction to settle an aggregate total of $2,600,000 of principal plus accrued interest owing on four deferred...read article.